BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18280355)

  • 1. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin.
    Clivati Brandt HR; de Lorenzo Messina MC; Belda Júnior W; Costa Martins JE; Criado PR
    Int J Dermatol; 2007 Dec; 46(12):1319-20. PubMed ID: 18173539
    [No Abstract]   [Full Text] [Related]  

  • 5. Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia.
    Cocuroccia B; Tonanzi T; Menaguale G; Fazio M; Girolomoni G
    Eur J Dermatol; 2002; 12(4):360-3. PubMed ID: 12095882
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
    Di Giacomo TB; Hussein TP; Souza DG; Criado PR
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
    Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    De Paulis S; Rossi E; Zamparelli R; Scapigliati A; Corrado M; De Stefano V
    Thromb Haemost; 2008 Feb; 99(2):441-2. PubMed ID: 18278197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe livedoid vasculopathy associated with antiphosphatidylserine-prothrombin complex antibody successfully treated with warfarin.
    Noda S; Asano Y; Yamazaki M; Ichimura Y; Tamaki Z; Takekoshi T; Sugaya M; Sato S
    Arch Dermatol; 2011 May; 147(5):621-3. PubMed ID: 21576587
    [No Abstract]   [Full Text] [Related]  

  • 14. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences.
    Meiss F; Marsch WC; Fischer M
    Eur J Dermatol; 2006; 16(2):159-62. PubMed ID: 16581568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of ischemic colitis associated with factor V Leiden mutation: successful treatment with anticoagulation.
    Chin BW; Greenberg D; Wilson RB; Meredith CG
    Gastrointest Endosc; 2007 Aug; 66(2):416-8. PubMed ID: 17524402
    [No Abstract]   [Full Text] [Related]  

  • 18. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of livedoid vasculopathy with extensive dermal capillary thrombi.
    Shimizu A; Tamura A; Yamanaka M; Amano H; Nagai Y; Ishikawa O
    J Dermatol; 2010 Jan; 37(1):94-7. PubMed ID: 20175829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.